ARID4B and hepatocellular carcinoma: In addition, it was reported that ARID4B acts as an oncogene in HCC, and increased ARID4B expression is correlated with vascular invasion, tumor node metastasis, tumor burden, high Edmondson–Steiner grades, and the poor prognosis of patients [106].